Kannel WB, Wolf PA, Benjamin EJ, et al: Prevalence, incidence, prognosis, and predisposing conditions for atrial fibrillation: population-based estimates. Am J Cardiol 82: 2N-9N, 1998
Wachtell K, Lehto M, Gerdts E, et al: Angiotensin II receptor blockade reduces new-onset atrial fibrillation and subsequent stroke compared to atenolol: the Losartan Intervention For End Point Reduction in Hypertension (LIFE) study. J Am Coll Cardiol 45: 712-719, 2005
Conen D, Tedrow UB, Koplan BA, et al: Influence of systolic and diastolic blood pressure on the risk of incident atrial fibrillation in woman. Circulation 119: 2146-2152, 2009
Born-Frontsberg E, Reineke M, Rump LC, et al: Participants of the German Conn’s Registry: Cardiovascular and cerebrovascular comorbidities of hypokalemic and normokalemic primary aldosteronism: results of the German Conn’s Registry. J Clin Endocrinol Metab 94: 1125-1130, 2009